Navigation Links
Cardium Launches New AWARE Clinical Study Website
Date:6/11/2008

rmation can be found at http://www.clinicaltrials.gov/ct/show/NCT00438867 and at Cardium's website at http://www.cardiumthx.com/flash/aware.html.

Currently, there are 49 participating AWARE sites in 32 states across the nation, including: Alabama (University of Alabama, Birmingham); Arizona (Banner Baywood Heart Hospital and Medical Center, Mesa; Southwest Heart, Tucson); California (Cardiovascular Medical Group of Southern CA, Beverly Hills; Cedars-Sinai Medical Center, Los Angeles; LA Cardiology Associates, Los Angeles; Mission Internal Medical Group, Mission Viejo; UCSD Medical Center, San Diego); Colorado (Aurora Denver Cardiology Associates, Aurora; South Denver Cardiology Associates, Littleton); District of Columbia (Cardiovascular Research Institute, Washington); Florida (Florida Hospital, Orlando; University of Florida, Gainesville); Georgia (St. Joseph's Research Institute, Atlanta); Idaho (St. Luke's Idaho Cardiology Associates, Boise); Illinois (Fox Valley Cardiovascular Consultants, Aurora; Midwest Heart Foundation, Lombard); Indiana (Northern Indiana Research Alliance, Fort Wayne; The Care Group, LLC, Indianapolis); Kentucky (CardioVascular Associates, Louisville); Massachusetts (Massachusetts General Hospital, Boston); Maine (Maine Medical Center, Portland); Michigan (William Beaumont Hospital, Royal Oak); Minnesota (Minneapolis Heart Institute, Minneapolis; St. Mary's Duluth Clinic, Duluth); Missouri (St. Anthony's Medical Center, St. Louis; St. Lukes Hospital, Kansas City); Nebraska (BryanLGH Heart Institute, Lincoln; The Cardiac Center of Creighton University, Omaha); New Jersey (The Valley Hospital, Ridgewood); New York (Lenox Hill Heart & Vascular Institute, New York; University of Rochester Medical Center, Rochester); North Carolina (Duke University Medical Center, Durham); Ohio (The Lindner C
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
11. Novozymes Launches Enzyme to Reduce Acrylamide in Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...Oct. 29 Ventaira Pharmaceuticals,announced today ...t leader,will acquire Ventaira,s assets and assist...ms of the acquisition were not disclosed. "We wil...s. In,addition, we will work closely with Battelle...yees," said Leslie Williams, President and CEO,of ...
..., Oct. 29 TorreyPines Therapeutics,Inc. (Nasdaq: ...dent and,Chief Executive Officer of TorreyPines, w...9th Annual Healthcare Conference in New York on Mo...t of Dr. Kurtz,s presentation will be available li...reypinestherapeutics.com . An archived version,of ...
..., Oct. 29 Immunosyn,Corporation (OTC Bulletin Boa...d Criner as the company,s Chief Financial and Acco... and Accounting Officer, Douglas A.,McCain, Jr., h... Board and,further retains his position as Corpora...logy and its resulting,biopharmaceutical product c...
Other Biology Technology:Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle 2Immunosyn Corporation Names G. David Criner as CFO 2
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 1Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 2Neuropathic pain 3A The sea provides a new hope of relief 9475 1Neuropathic pain 3A The sea provides a new hope of relief 9475 2Demi Lovato Joins National Bullying Prevention Movement 53681 1Demi Lovato Joins National Bullying Prevention Movement 53681 2
...maceuticals, Inc. today announced that it has been...vation Research Grant (SBIR) from the National Ins... Institutes of Health (NIH) to develop in vivo zeb...rome (CYP) P450s. CYP profiling, a critical step ...rug Administration (FDA) for all new drug approval...
...the University of Florida, has donated $250,000 to...e establishment of an endowment to award creative ... find alternative solutions to problems that signi...t from the $250,000 will be presented to the winne...Innovation and Creativity in Entomology. , "I wan...
...is. Pop culture heedlessly and wrongly lumps th... paleontologists assumed that because the creature...sing only two legs to take flight. , Now comes...aunching some 500 pounds of reptilian heft into fl...re ultra-strong wings which, when folded and balan...
Other Biology News:NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays 2Florida professor creates endowment for insect scientists 2Four, three, two, one . . . pterosaurs have lift off 2
Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals
Rabbit Anti-Human Reptin / TIP49B / RUVB2 Polyclonal Antibody, Unconjugated from Abcam
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: